{"DataElement":{"publicId":"3371380","version":"1","preferredName":"Lymphatic Invasion Carcinoma Surgical Procedure Involvement Indicator","preferredDefinition":"Text indicator to signify the presence of tumor invasion within lymphatic vessels.","longName":"3027935v1.0:3371378v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3027935","version":"1","preferredName":"Lymphatic Invasion Carcinoma Surgical Procedure Involvement","preferredDefinition":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels._A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004_A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._To have a connection by participation or association or use; sharing in an activity or process.","longName":"LYM_INV_SURG_INVL","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3027932","version":"1","preferredName":"Lymphatic Invasion","preferredDefinition":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels.","longName":"C47850","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphatic Invasion","conceptCode":"C47850","definition":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82115195-3BD1-9CE8-E040-BB89AD431D86","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3027933","version":"1","preferredName":"Carcinoma Surgical Procedure Involvement","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004:A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.:To have a connection by participation or association or use; sharing in an activity or process.","longName":"C2916:C15329:C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82115195-3BE3-9CE8-E040-BB89AD431D86","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82115195-3BF4-9CE8-E040-BB89AD431D86","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3371378","version":"1","preferredName":"Yes No Equivocal Unknown Indicator","preferredDefinition":"The affirmative response to a question or activity._The non-affirmative response to a question._Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance._Not known, not observed, not recorded, or refused._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"YES_NO_EQ_UNK_IND","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3006497","version":"1","preferredName":"Yes","longName":"3006497","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EC92F2E-CFE9-DB85-E040-BB89AD435186","latestVersionIndicator":"Yes","beginDate":"2010-02-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-02-04","modifiedBy":"COOPERM","dateModified":"2015-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B85BD33E-6AF5-07C2-E040-BB89AD430D59","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3216924","version":"1","preferredName":"No","longName":"3216924v1.00","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FB8B94D-C670-2CB0-E040-BB89AD4377A2","latestVersionIndicator":"Yes","beginDate":"2011-03-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2011-03-30","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B85BD33E-6B00-07C2-E040-BB89AD430D59","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"Equivocal","valueDescription":"Equivocal","ValueMeaning":{"publicId":"3030154","version":"1","preferredName":"Equivocal","longName":"3030154","preferredDefinition":"Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Equivocal","conceptCode":"C86071","definition":"Open to question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82B0A0A7-9BBB-0E57-E040-BB89AD433700","latestVersionIndicator":"Yes","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B85BD33E-6B0B-07C2-E040-BB89AD430D59","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"Unknown/Not Reported","valueDescription":"Unknown","ValueMeaning":{"publicId":"3371379","version":"1","preferredName":"Unknown","longName":"3371379","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B85BD33E-6B16-07C2-E040-BB89AD430D59","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B85BD33E-6B2E-07C2-E040-BB89AD430D59","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3371377","version":"1","preferredName":"Yes No Equivocal Unknown Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. :Not known, not observed, not recorded, or refused.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3371377v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Equivocal","conceptCode":"C86071","definition":"Open to question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B85BD33E-6AD1-07C2-E040-BB89AD430D59","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B85BD33E-6AE2-07C2-E040-BB89AD430D59","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"},{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"LYPM_INV_CARC_INVLM_IND","type":"OID, Theradex","context":"Theradex"}],"ReferenceDocuments":[{"name":"Lymphovascular invasion","type":"Preferred Question Text","description":"Lymphovascular invasion","url":null,"context":"NCIP"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B85BD33E-6B39-07C2-E040-BB89AD430D59","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"SOKKERL","dateModified":"2018-12-27","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}